NDC 17135-208-16 - THRUSH RELIEF
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17135-208
- Requested NDC
- 17135-208-16
- Package NDCs from labels
- 17135-208-16
- Manufacturer
- Farnam Companies, Inc. | FIRST PRIORITY INCORPORATED
- Effective date
- 2023-10-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| THRUSH RELIEF - Farnam Companies, Inc. | FIRST PRIORITY INCORPORATED | Farnam Companies, Inc. | FIRST PRIORITY INCORPORATED | 2023-10-05 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17135-208-16 | THRUSH RELIEF | 473 mL in 1 BOTTLE, DISPENSING | LIQUID | 473 | 6 | |
| 17135-208-16 | THRUSH RELIEF | 12 in 1 CASE | LIQUID | 12 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| COPPER NAPHTHENATE | ACTIVE INGREDIENT | 9J2IBN2H70 | THRUSH RELIEF (COPPER NAPHTHENATE) LIQUID [FARNAM COMPANIES, INC.] | 2 | |
| COPPER | ACTIVE MOIETY | 789U1901C5 | THRUSH RELIEF (COPPER NAPHTHENATE) LIQUID [FARNAM COMPANIES, INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| COPPER | CUPRIC CHLORIDE | Hospira, Inc. | a84d61a4-8e7f-4be1-aba6-f633b334aafc | 2026-05-18 | Warnings, Adverse reactions | COPPER |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.